Quantum Biopharma Ltd
(QNTM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 446 | 1,498 | 3,518 | 5,996 | 3,120 |
| Marketable Securities | 5,844 | 5,084 | 2,763 | 2,064 | 3,485 |
| Receivables | 2,936 | 3,039 | 3,412 | 3,807 | 7,088 |
| Inventories | 78 | 77 | 94 | 117 | N/A |
| Other current assets | 0 | 193 | 0 | 0 | 0 |
| TOTAL | $9,343 | $10,344 | $9,932 | $12,053 | $13,844 |
| Non-Current Assets | |||||
| PPE Net | 70 | 72 | 74 | 77 | 65 |
| Investments And Advances | 0 | 0 | 2 | 2 | 6 |
| Intangibles | 4,619 | 4,725 | 4,830 | 4,934 | 5,040 |
| Other Non-Current Assets | 121 | 156 | 35 | 54 | 72 |
| TOTAL | $4,810 | $4,953 | $4,942 | $5,067 | $5,183 |
| Total Assets | $14,153 | $15,297 | $14,874 | $17,119 | $19,027 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,088 | 3,193 | 2,357 | 4,362 | 3,308 |
| Other current liabilities | 2 | 7,792 | 5,707 | 492 | 73 |
| TOTAL | $6,647 | $13,250 | $10,344 | $6,679 | $3,681 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 1,000 | 1,000 | N/A |
| Other Non-Current Liabilities | -571 | 513 | 0 | 284 | 188 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $6,647 | $13,250 | $10,344 | $6,679 | $3,681 |
| Shareholders' Equity | |||||
| Common Shares | 169,028 | 159,962 | 153,036 | 150,470 | 149,081 |
| Retained earnings | -195,260 | -189,941 | -180,688 | -172,111 | -166,751 |
| Other shareholders' equity | 160 | -557 | 223 | 1,008 | 1,887 |
| TOTAL | $7,507 | $2,047 | $4,529 | $10,440 | $15,346 |
| Total Liabilities And Equity | $14,153 | $15,297 | $14,874 | $17,119 | $19,027 |